Dr. Sadie Dobrozsi on the Importance of Genetic Testing in Breast Cancer
By Dr. Sadie Dobrozsi, Evolent, Rob Dillard - Last Updated: March 26, 2025Dr. Sadie Dobrozsi, medical director of genetic testing and oncology imaging at Evolent, spoke to DocWire News about the importance of genetic testing in breast cancer to better understand the disease. Dr. Dobrozsi also spoke about why many breast cancer survivors who qualify for genetic testing aren’t getting it, and more.
Advertisement
Advertisement
Related Posts
Dr. Sadie Dobrozsi discusses the importance of "pan-cancer" testing, especially as it pertains to breast cancer.
The most frequent changes detected were additional copies of chromosome 1q and losses of chromosomes 10q, 16q, and 22.
Heterozygosity in BRCA1 genes is not enough to prevent tumor proliferation, according to researchers out of Harvard.
Researchers designed a interpretable deep learning model for detecting BRCA pathogenic variants of breast cancer.
This could be a needed breakthrough for those predisposed to breast and ovarian cancer mutations.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.